Article Name China
Invisalign® Palatal Expander Gains Approval in China for Growing Patients
Align Technology’s non-invasive orthodontic innovation set to transform pediatric care in China.
16th May, 2025
SWS Medical Strengthens Commitment to Advancing Healthcare Access in Africa
Company Expands Regional Presence with Focus on Medical Innovation and Infrastructure Development
15th April, 2025
Baird Medical Showcases Advanced MWA Technology to UCLA Expert – China
Cross-Border Collaboration Highlights Progress in Minimally Invasive Tumor Treatment Innovations
15th April, 2025
Baird Medical Highlights Advanced MWA Technology with UCSF Expert in China
Guangzhou & Shenzhen Events Showcase Innovation in Microwave Ablation for Precision Treatment
03rd April, 2025
Peijia Medical & dsm-firmenich Partner in China to Develop Innovative Medical Devices
Collaboration Aims to Advance Cutting-Edge Solutions for Improved Patient Care
02nd April, 2025
Baird Medical Wins "Most Valuable Investment Award" for AI Tumor Ablation Surgical Robot at 10th China Medical Industry Innovation Competition
Pioneering AI-driven robotics system poised to redefine precision medicine and transform minimally invasive surgery worldwide.
17th March, 2025
NAMSA acquires WuXi AppTec’s US medical device testing operations to expand expertise and capacity
The acquisition strengthens NAMSA’s leadership in medical device biological safety testing, adding expertise, lab capacity, and scientific resources to support global manufacturers.
04th March, 2025
China’s 91st CMEF to Showcase Next-Gen Medical Innovations and Global Industry Trends
Bringing together industry leaders, healthcare professionals, and tech pioneers, the event will spotlight AI-driven diagnostics, robotics, smart wearables, and the future of precision medicine.
03rd March, 2025
Baird Medical Expands Global MWA Training in China with Expert-Led Program in Guangzhou
The initiative enhances medical education by equipping healthcare professionals with advanced Microwave Ablation techniques to improve cancer treatment outcomes worldwide.
27th February, 2025
New Perennial Tianjin Medical Cluster Opens, Introducing China’s First Wholly Foreign-Owned Private Tertiary Hospital
Developed by Perennial Holdings, the state-of-the-art healthcare hub integrates world-class medical, eldercare, and specialty services, enhancing China’s private healthcare landscape. Developed by Perennial Holdings, the state-of-the-art healthcare hub integrates world-class medical, eldercare, and specialty services, enhancing China’s private healthcare landscape.
27th February, 2025
China Approves ZEISS VISUMAX® 800 with SMILE® Pro, Elevating Laser Vision Correction Standards
The next-generation femtosecond laser enhances surgical precision, reduces treatment time, and integrates AI-driven features, reinforcing ZEISS’ leadership in refractive surgery innovation.
27th February, 2025
EyeYon Medical expands operations with New Subsidiary in China
The move aims to strengthen EyeYon’s presence in Asia and enhance access to its innovative ophthalmic solutions.
05th February, 2025
CMU Healthcare and Nobel Laureate Randy Schekman pioneer advances in Exosome Technology
Collaboration explores groundbreaking applications in cellular communication and therapy.
16th January, 2025
Medtech Mavericks: Startups Redefining Global Healthcare in 2025
Aktiia, Resolve Medical, SmartMore, Qritive, Elemy, Mendaera, Biolinq, Endiatx, Glooma, Neuroglee Therapeutics
10th January, 2025
HMPV and Respiratory Infections on the Rise in China: Health Officials Monitor Flu Season Impact
Health Officials emphasize seasonal nature of respiratory illness Surge, with expected drop in 2024 cases
07th January, 2025
Human Metapneumovirus (HMNPV): Rising Concerns Over a Growing Health Threat
With symptoms mimicking common respiratory illnesses, Human Metapneumovirus (HMNPV) is placing vulnerable populations at risk and straining healthcare systems. Learn the key precautions to stay safe.
06th January, 2025
Cytokinetics and Sanofi partner to develop aficamten in Greater China
Sanofi secures rights to advance and commercialize aficamten for cardiac care.
20th December, 2024
Everest Medicines announces first VELSIPITY prescription in Greater Bay Area
Everest Medicines marking a milestone in benefiting Mainland China patients
18th December, 2024
Medtech Special
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer